Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Current Assets (2017 - 2025)

Historic Current Assets for Serina Therapeutics (SER) over the last 9 years, with Q3 2025 value amounting to $11.5 million.

  • Serina Therapeutics' Current Assets rose 11200.44% to $11.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.5 million, marking a year-over-year increase of 11200.44%. This contributed to the annual value of $5.7 million for FY2024, which is 2550.2% down from last year.
  • According to the latest figures from Q3 2025, Serina Therapeutics' Current Assets is $11.5 million, which was up 11200.44% from $8.0 million recorded in Q2 2025.
  • Serina Therapeutics' Current Assets' 5-year high stood at $11.5 million during Q3 2025, with a 5-year trough of $1.1 million in Q3 2023.
  • Its 5-year average for Current Assets is $4.2 million, with a median of $2.2 million in 2021.
  • Per our database at Business Quant, Serina Therapeutics' Current Assets skyrocketed by 56051.85% in 2024 and then plummeted by 3561.6% in 2025.
  • Quarter analysis of 5 years shows Serina Therapeutics' Current Assets stood at $2.2 million in 2021, then grew by 9.8% to $2.5 million in 2022, then soared by 210.6% to $7.6 million in 2023, then dropped by 25.5% to $5.7 million in 2024, then skyrocketed by 102.55% to $11.5 million in 2025.
  • Its Current Assets was $11.5 million in Q3 2025, compared to $8.0 million in Q2 2025 and $5.8 million in Q1 2025.